Medication-free

depression treatment

Brain stimulation headset that reduces depression

A lifestyle app developed by psychologists​

CE certified as a medical device in the EU and UK

  • Brain stimulation headset that reduces depression​
  • A lifestyle app developed by psychologists​
  • CE certified as a medical device in the EU and UK
30-day home trial: Trial Flow for 30 days at home. No risk. No obligation.

Consult a doctor or other healthcare professional before use.

“A medically approved treatment option that doesn’t involve medication and can be self-administered? Amazing.” – Glamour Magazine

What is Flow?

According to the World Health Organisation, depression is the leading cause of disability worldwide1. Flow is a medical device and therapy app designed to treat depression. It is the first of its kind available in Europe to buy and use at home. Flow is suitable for people aged 18 years and older with a depression diagnosis.

How does it work?

People diagnosed with depression often have a lower activity in the left frontal cortex of their brain. The Flow medical device delivers a gentle electrical signal to stimulate this area and rebalance activity. During this process, users interact with a virtual therapy app which provides information and advice on various topics, including improved sleep, nutrition, meditation and exercise.
Read more

Play Video

Flow is approved for treatment of Major Depressive Disorder (depression) in the EU and UK.

You must be over 18 years of age to use Flow.

Be first to know when Flow is available in your country:

*No spam, ever. Emails are never shared.

Effective

The Flow headset uses a type of neurostimulation which, in clinical studies, has been shown to have approximately the same effect as antidepressant medication, with fewer and less-severe side effects. The lifestyle techniques taught in the app are based on rigorous scientific research and have been shown in clinical studies to reduce depression.
Read more

Safe

The technology that underpins Flow has been deemed safe by the scientific community. In a large 2016 safety review, leading researchers in the field concluded that this type of brain stimulation in human trials did not produce any serious adverse effects or irreversible injuries.
Read more

Home-based

There are many treatments for depression, but more options are needed. Flow increases choice by providing people with a safe, effective and medication-free treatment. It is the first medical device of its kind available in Europe to buy and use from the comfort and privacy of your home. 
Read more

Certified

Flow is a certified medical device intended for use as a treatment for depression. In Europe, Flow is classified as a class IIa medical device. This means that the company and the claims we make is subject to assessments and audits performed at regular intervals by the British Standards Institution (BSI)Flow Neuroscience is a certified medical device manufacturer according to ISO 13485:2016.

Read more

The science behind Flow

The Flow headset uses a brain stimulation technique called tDCS (short for transcranial direct current stimulation). tDCS has been researched for many different conditions over the last 20 years.

The results of these studies indicate that tDCS has approximately the same effect as antidepressant medication – but with fewer and less-severe side effects. The result of a recent randomised controlled trial (RCT) study on 245 patients shows that 41% of the patients had a 50% reduction or more in their depression symptoms.
Read more

The results of a recent randomised controlled trial (RCT) on tDCS. The Flow device is using the same treatment protocol as in this study.  

Hi! I'm Flow

I will help you understand, treat and prevent depression

The Flow – Depression app represents a new chapter in the understanding and treatment of depression, and is based on the latest psychology and neuroscience research.

Read more

Medical advisors

Andre Brunoni MD PhD.

Assoc. Professor of Psychiatry at the University Hospital of Sao Paulo, Brazil. World-leading tDCS researcher.

“By combining tDCS with behavioral therapy, the Flow team has created a powerful treatment solution.” 

Sophia Frangou MD PhD.

Professor of Psychiatry at Mount Sinai in New York, USA. Editor-in-Chief of European Psychiatry.

“Home-based, on-demand treatment that is safe and evidence-based, as that provided by Flow Neuroscience, is a major step forward in meeting the clinical needs of patients with depression.”

As featured in